BioXcel Therapeutics(BTAI) - 2023 Q3 - Quarterly Report

Table of Contents ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 Delaware 82-1386754 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 555 Long Wharf Drive New Haven, CT 06511 (Address of principal executive offices) (Zip Code) (475) 238-6837 (Registrant's telephone number, including area code) N/A (Former name, former address and former fiscal year, if changed since ...